TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Successful recanalization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of stained area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete bacterial elimination (residual bacteria < 1%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregivers' assessment of hearing ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance on the Flanker test of inhibitory control and attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final Reading and Mathematical ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of patients showing an immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: survivorship free from reoperation
Endpoint domain: Mortality/survival
Primary endpoint: survivorship free from revision
Endpoint domain: Mortality/survival
Primary endpoint: mean OKS (Oxford Knee Score)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Increase in skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: overall rate of any complication
Endpoint domain: Adverse events/effects
Primary endpoint: total posterior capsular tear rate
Endpoint domain: Adverse events/effects
Primary endpoint: Missed kindergarten days in total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days missed due to fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of herpes simplex
Endpoint domain: Adverse events/effects
Primary endpoint: higher pregnancy viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Push out bond strength (PBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of failures at adhesive interfaces
Endpoint domain: Adverse events/effects
Primary endpoint: Consumption of rescue opioids
Endpoint domain: Adverse events/effects
Primary endpoint: Proclination of incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bonding failures
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of ABO scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extensor muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear-avoidance related to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge level about cervical cancer and Pap smear test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavior of Pap smear test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intraoperative tendency of oozing
Endpoint domain: Adverse events/effects
Primary endpoint: Leak of colonic anastomosis
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in the angle of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thirst as an indicator of fluid needs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent for puncturing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of ataxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: opioids consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum IL-1ra levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Task reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate for administering NG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate for administering IG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac index stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: T-cell and T-helper cell percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anxiety levels during the procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain levels during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving for tobacco
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental quality-adjusted life-years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child quality-adjusted life-years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: LVEF increase at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: End-systolic volume at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LDL-cholesterol changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum insulin changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: VAS overall SAR symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average drinks/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver mental health scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ability to manage emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conversion rate to open surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inflammation factors (C-reactive protein, IL-6, IL-18, tumor necrosis factor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum concentrations of malondialdehyde, nitric oxide synthase, and nitric oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite incidence of hospital admission for HF and all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Participant enjoyment of the program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: genomic instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttest scores for knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttest scores for attitude
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Higher recommendation score for VRdocs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postprandial %FMD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial insulin AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral vasospasm rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hazard ratio estimate within 95% CI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regulatory or estimate agreement success criteria fulfilled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-task state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anti-saccade errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response latencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hip BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: syndesmotic motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sedentary time (ST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in fatigue interference
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cost of antenatal care and delivery-related healthcare use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Calprotectin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pH levels in the large intestine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensory and motor block onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic need
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease of plasmatic norepinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire Overall Summary Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Metabolomic markers of cardiovascular health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lower physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher RPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned 30-day readmission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with an improved clinical composite score (CCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from MPP system related adverse events requiring additional invasive intervention
Endpoint domain: Adverse events/effects
Primary endpoint: newly detected early syphilis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of indications supported by at least 2 pivotal trials
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of indications supported by only single-group pivotal trials
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion supported by at least 1 pivotal trial of 6 months' duration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: composite of all-cause death, myocardial infarction, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: saliva-buffer capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness and volume of cartilage defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinical and radiographic scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean rate of perceived exertion (RPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: columellar angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nostril width on the cleft side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nostril height on the cleft side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized cognition measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: problem-solving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPA (Symptom Prevalence Assessment)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: EDs (Emotional Distress)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: catheterization success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: successful catheterisation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reliability of ASQ-3 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in FPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in PPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean morphine-equivalent units (MEUs) at 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean morphine-equivalent units (MEUs) at 48 hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative pain and discomfort severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative sore throat discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative vaccine take after three doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAARS-O score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate (20% reduction in CAARS-O score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction with pillbox usage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to dosing schedule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: optimal timing for complete revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of high systolic PAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Weighted average annual incremental costs per beneficiary
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: levels of diamine oxidase (DAO), lactulose/mannitol (L/M), β2‐microglobulin, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBD) and cardiac troponin l (cTnl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of resting energy expenditure (REE), serum catecholamines, glucagon, lactate and Homeostasis model assessment (HOMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental health outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of major and life-threatening bleeding complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: pain knowledge improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Systematic oxidative stress score (SOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis prediction accuracy (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Avoiding liver damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: mYPAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parents' satisfaction of anesthesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: levels of total indoxyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: levels of free p‐cresyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: stone removal efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SFA intake (% total energy intake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative VAS scores
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: self-care trajectories
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean improvement in MADRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate (≥ 50% improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate (MADRS score ≤ 10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma glucose during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: patients perception of malodor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nasal obstruction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breast cancer risk in postmenopausal women reporting hot flushes
Endpoint domain: Mortality/survival
Primary endpoint: Number of mild and moderately severe ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Delphi consensus attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of aberrant morae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strain element in GRBAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VHI and VAS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glasgow Coma Score on the 6th day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative doses of morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of MSI-195
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax under fed conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haemodynamic response (hypertension and tachycardia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GSLTPAQ scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6 MWT performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-s STS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl‐Meyer leg function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased green vegetable consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Freedom from any amputation and target lesion/vessel revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: VAS score at movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to deterioration (TTD) of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of diagnosis and classification of labrum injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in disability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit rate at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retention at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epithelial injury scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: percentage of VSA denudation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Distance walked in 6-min test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Spherical equivalent measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest reliability of refraction methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in MFIS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Estimated number of female sex workers (FSWs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of POUR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mercury Urine Concentration (Hg-U)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in olfactory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in odour thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LUTS incidence in asymptomatic men
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LUTS progression in symptomatic men
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of participants in opioid agonist treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in self-reported opioid use outside treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative IKDC and Lysholm scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes